Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran Efficacy and DNIC in Fibromyalgia
NCT01747044Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Apr 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing Milnacipran with Placebo (2 arms). Primary endpoint: Pain scores on the verbal numeric scale at 1 month. Status: unknown.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01747044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01747044.